Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 18:27:101163.
doi: 10.1016/j.resplu.2025.101163. eCollection 2026 Jan.

Vasopressin, steroids, and epinephrine in out-of-hospital cardiac arrest - a protocol for a randomized controlled trial (OHCA REVIVES trial)

Affiliations

Vasopressin, steroids, and epinephrine in out-of-hospital cardiac arrest - a protocol for a randomized controlled trial (OHCA REVIVES trial)

Ying-Chih Ko et al. Resusc Plus. .

Abstract

Objective: Several clinical trials have shown promising results for the vasopressin-steroid-epinephrine (VSE) triple therapy in patients experiencing in-hospital cardiac arrest (IHCA); however, this treatment strategy has not yet been studied in the prehospital setting. The OHCA REVIVES (A Randomized Clinical Trial of Patient Outcomes Following Out-of-Hospital Cardiac Arrest Receiving Epinephrine Versus In-together Vasopressin, Epinephrine, and Steroid) trial aims to evaluate the effectiveness of the VSE combined therapy in improving clinical outcomes in patients with out‑of‑hospital cardiac arrest (OHCA).

Methods: The OHCA REVIVES trial is an investigator-initiated, multicenter, superiority cluster randomized controlled trial. Adult non-traumatic patients with OHCA treated by six participating advanced ambulance teams in Taipei and New Taipei City, Taiwan will be included. Biweekly randomized clusters of participating advanced ambulance teams were assigned to administer either VSE combined therapy or standard care during cardiac arrest. The primary outcome is sustained return of spontaneous circulation (ROSC ≥ 2 h), and key secondary outcomes include prehospital ROSC, survival to hospital discharge, and survival with favorable neurologic outcomes (cerebral performance category score ≤ 2) at hospital discharge. A total of 1344 patients will be included.

Conclusion: The OHCA REVIVES trial is expected to provide new insights into pharmacological strategies for the treatment of OHCA.Trial registration:ClinicalTrials.gov (identifier: NCT06203847; date registered: January 12, 2024).

Keywords: Cardiac arrest; Clinical trial protocol; Epinephrine; Steroid; Vasopressin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests or personal relationships that could have influenced the work reported in this paper.

Figures

Fig. 1
Fig. 1
Proposed CONSORT flow diagram. OHCA, out-of-hospital cardiac arrest; VSE, vasopressin-steroid-epinephrine; ITT, intention-to-treat.
Fig. 2
Fig. 2
Ampoule dispensing device: (A) three-dimensional model design schematic and (B) completed final product.

References

    1. Martin S.S., Aday A.W., Allen N.B., et al. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025;151:e41–e660. - PMC - PubMed
    1. Lin H.Y., Chien Y.C., Lee B.C., et al. Outcomes of out-of-hospital cardiac arrests after a decade of system-wide initiatives optimising community chain of survival in Taipei city. Resuscitation. 2022;172:149–158. - PubMed
    1. Wang C.Y., Wang J.Y., Teng N.C., et al. The secular trends in the incidence rate and outcomes of out-of-hospital cardiac arrest in Taiwan–a nationwide population-based study. PLoS One. 2015;10 - PMC - PubMed
    1. Myat A., Song K.J., Rea T. Out-of-hospital cardiac arrest: current concepts. Lancet. 2018;391:970–979. - PubMed
    1. Ong M.E.H., Perkins G.D., Cariou A. Out-of-hospital cardiac arrest: prehospital management. Lancet. 2018;391:980–988. - PubMed

Associated data

LinkOut - more resources